Market News & Trends
How the Need for an Alternative Oral Dosage Form Delivered a Patient-Centric Drug Formulation
Dysphagia can affect many people throughout their lifetime. It also represents a challenge for oral drug manufacturers. Dysphagia not only impacts patients’ ability to take…
Vetter Wins Two Coveted Awards for Syringe Closure System
The World Packaging Organization (WPO) has awarded Vetter the WorldStar Award 2016 for its syringe closure system Vetter-Ject. The WorldStar competition is one of the…
Inovio Pharmaceutical's DNA Vaccine for Zika Virus Induces Robust Immune Responses
Inovio Pharmaceuticals, Inc. recently announced that preclinical testing of its synthetic vaccine for the Zika virus induced robust and durable immune responses, demonstrating the potential…
Emergent BioSolutions’ Auto-Injector Platform Selected by US Department of Defense & Battelle
Emergent BioSolutions Inc. recently announced that Emergard, the company’s ruggedized, military-grade auto-injector platform, has been selected by the US Department of Defense (DoD) and Battelle…
Galapagos Starts SAPHIRA Phase II Study With GLPG1837 in Cystic Fibrosis Patients
Galapagos NV recently announced the first dosing in its Phase II exploratory program of GLPG1837 in patients with cystic fibrosis (CF). GLPG1837 is a candidate…
Unilife & Amgen Enter Strategic Collaboration for Injectable Drug Delivery Systems; Amgen to Invest up to $75 Million
Unilife Corporation recently announced a strategic collaboration with Amgen for injectable drug delivery systems. The collaboration, which includes licensing, investment, development, and supply agreement components,…
First Prescription Drug Reaches European Market With Advancia
Six months after the successful industrialization of Nemera’s next-generation nasal spray pump, Advancia is on the European market with an intranasal corticosteroid suspension treating allergic…
Protea Announces Collaborative Partnership With Protein Metrics
Protea Biosciences Group, Inc. recently announced it is collaborating with Protein Metrics Inc., a premier provider of software solutions for the comprehensive characterization of proteins,…
Hype Surrounding Cancer T-Cell Therapy Overlooks Safety & Cost Concerns
Although excitement surrounding recent trials of T-cell therapies and their ability to treat blood cancer has been widespread of late, there are lingering questions about…
Capsugel & Pulmatrix Enter Collaboration to Develop & Manufacture Novel Inhaled Therapeutics
Capsugel and Pulmatrix, Inc. have recently formed a collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases. The agreement provides Capsugel exclusive rights…
VBI Vaccines Announces Vaccine Stability Collaboration With GlaxoSmithKline
VBI Vaccines Inc. has entered into a research collaboration with GlaxoSmithKline Biologicals SAto evaluate VBI’s LPV Platform, a proprietary formulation and process that enables the…
ZIOPHARM Announces First Patient Enrolled in Phase I Study; Drug Uses Sleeping Beauty Platform
ZIOPHARM Oncology, Inc. recently announced that the first patient has been enrolled in a Phase I clinical study of its second-generation non-viral CD19-specific chimeric antigen…
BioXcel Expands Into CNS Orphan Disease Therapeutics
BioXcel Corporation recently announced its expansion into CNS Orphan Diseases that require novel treatment solutions for neurological manifestations, including neurodegenerative disorders, motor dysfunction disorders, and…
RedHill Biopharma Announces Collaboration With Germany's Fraunhofer Institute
RedHill Biopharma Ltd. recently announced a research collaboration with Leipzig-based Fraunhofer Institute for Cell Therapy and Immunology (IZI), a research unit of the Fraunhofer Society…
ICON Selected by Genomics England to Support Largest Genome Sequencing Project
ICON plc recently announced it has been selected by Genomics England as data management partner for the 100,000 Genomes Project. A ground-breaking project announced by…
Biota Commences Dosing in Phase II Trial of Antiviral Therapy
Biota Pharmaceuticals, Inc. recently announced that the first patient has been dosed in a Phase II double-blind, randomized, placebo-controlled trial to evaluate the safety, tolerability…
West's Daikyo Crystal Zenith® Cyclic Olefin Polymer Selected by Amgen
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently announced that global biotechnology leader Amgen Inc. has utilized…
NGS & Cloud Computing Driving Big Growth in Global Bioinformatics Markets
Next-generation sequencing (NGS) technology has fueled the genomics revolution, making it possible to sequence an entire human genome within days for a few thousand dollars.…
XBiotech Engages in Research for Heart Attack Antibody Therapy
XBiotech Inc., developer of True Human™ therapeutic antibodies, announced today the signing of a Material Transfer Agreement (MTA) with Brigham and Women’s Hospital and Massachusetts…
Merck’s Zepatier Will Threaten the Dominance of Gilead’s Harvoni in Hepatitis C Market
The introduction of Merck and Co.’s recently-approved drug Zepatier (elbasvir/grazoprevir) to the hepatitis C treatment space will shake up a market long-dominated by Gilead. The…
